A new ketoconazole topical gel formulation in seborrhoeic dermatitis: An updated review of the mechanism

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 9, 2007, Pages 1365-1371

  Faergemann, Jan ^a   Borgers, M ^b   Degreef, Hugo ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Anhydrous gel; Anti inflammatory; Antifungal; Malassezia spp.; Seborrhoeic dermatitis; Xolegel

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; CORTICOSTEROID; DESONIDE; HORMONE; KETOCONAZOLE; PYRROLE DERIVATIVE; SALICYLIC ACID; SELENIUM SULFIDE; SULFUR; TAR; UNCLASSIFIED DRUG; XOLEGEL; ZINC OXIDE;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CELL PROLIFERATION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG TOLERABILITY; EAR; EYEBROW; HUMAN; MALASSEZIA; NONHUMAN; PHARMACODYNAMICS; PITYROSPORUM; REVIEW; SCALP; SEBORRHEIC DERMATITIS; SKIN INFECTION; SKIN INFLAMMATION; SKIN IRRITATION; GEL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; DERMATITIS, SEBORRHEIC; GELS; HUMANS; KETOCONAZOLE;

EID: 34250865592     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.8.9.1365     Document Type: Review

References (42)

1. SHUSTERS: The actiology of dandruff and the mode of action of therapeutics agents. Br. J. Dermatol. (1984) 111:235-242.
2. CARR MM, PRYCE DM, IVE FA. Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to ketoconazole. Br. J. Dermatol. (1987) 116:212-216.
3. FAERGEMANN J: Management of seborrhoeic dermatitis. Am. J. Clin. Dermatol. (2000) 1:75-80.
4. PIERARD-FRANCHIMONT C, PIERARD G: A double-blind placebo-controlled study of ketoconazole and desonide get combination in the treatment of facial Seborrhoeic dermatitis. Dermatology (2002) 204:344-347.
5. GREEN CA, FARR PM, SHUSTER S: Treatment of seborrhoeic dermatitis with ketoconazole: II. Respons of the face, scalp and trunk to topical ketoconazole. Br. J. Dermatol. (1987) 116:217-221.
6. BERGBRANT IM, FAERGEMANN J: The role of pitysporum ovale in seborrhoeic dermatitis. Semin. Dermatol. (1990) 9:262-268.
7. HAY RJ, GRAHAM-BROWN RAC: Dandruff and seborrhoeic dermatitis: causes and treatment. Clin. Exp. Dermatol. (1997) 22:3-6.
8. GUEHO E, BOEKHOUT T, ASHBEE HR, GUILLOT J, VAN BELKUM A, FAERGEMANN J: The role of Malassezia species in the ecology of human skin and as pathogens. Med. Mycol. (1998) Suppl. 1:220-229.
9. BERGBRANT IM: Seborrhoeic dermatitis and pitysporum yeasts. In: Current Topics in Medical Mycology. Borgers M, Hay R, Rinaldi MG (Eds). Springer Verlag, New York, (1995) 6:95-112.
10. RAN Y, YOSHIIKE T, OGAWA H: Lipase of Malassezia furfur: Some properties and their relationship to cell growth. J. Med. Vet. Mycol. (1993) 3:77-85.
11. FORD GP, FARR PM, IVE FA, SHUSTER S: The response of seborrhoeic dermatitis to keroconazole. Br. J. Dermatol. (1984) 111:603-607.
12. ORTONNE JP, LACOUS JP, VITETTA A. LE FICHOUX Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. Dermatology (1992) 184:275-280.
13. NEUMANN HAM, BERRETTY PJM: Treatment of pityrosporum folliculitis with ketoconazole. Mykosen. (1981) 24(3):167-171.
14. ELEWSKI B, LING MR, PHILLIPS TJ: Efficacy and safety of a new once daily topical ketoconazole 2% gel in the treatment of Seborrhoeic dermatitis: a Phase III trial. J. Drugs Dermatol. (2006) 5:646-650.
15. HEERES J, BACKX LJJ, MOSTMANS JH, VAN CUTSEM J: Antimycotic imidazoles. Part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J. Med. Chem. (1979) 22:1003-1005.
16. VANDEN BOSSCHE H: Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. In: Current Topics in Medical Mycology. McGinnis MR (Ed.). Springer, New York (1985) 1:313-359.
17. BORGERS M: Ultrastructural correlates of antimycotic treatment. In: Current Topics in Medical Mycology. McGinnis M (Ed.), Springer, Berlin, (1988) 2:1-39.
18. VAN CUTSEM J, VAN GERVEN F, VAN PEER A, WOESTENBORGHS R, FRANSEN J, JANSSEN PA. Ketoconazole: activité in vitro sur pitysporum. Efficacité dans la pitysporose experimentale du cobaye et dans le pityriasis capitis humain. Bull. Soc. Française Myc Med. (1988) 17:283-294.
19. PIERARD-FRANCHIMONT C, ARRESE JE, PIERARD GE: How to manage Seborrhoeic dermatitis? Rev. Med. Liège (2003) 58:67-69
20. SKINNER RB, NOAH PW, TAYLOR RM et al.: Double-blind treatment of Seborrhoeic dermatitis with 2% ketoconazole cream. J. Am. Ac. Dermatol. (1985) 12:852-856.
21. IVE FA. An overview of experience with ketoconazole shampoo. Br. J. Clin. Pract. (1991) 45:279-284.
22. PETER RM, BARTHAUER V: Successful treatment and profylaxis; of scalp Seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br. J. Dermatol (1995) 132:441-445.
23. PIÉRARD GE, PIÉRARD-FRANCHIMONT C, VAN CUTSEM J et al.: Ketoconazole 2% emulsion in the treatment of Seborrhoeic dermatitis. Int. J. Dermatol. (1991) 30:806-809.
24. HAMMER KA, CARSON CF, RILEY TV: In vitro activities of ketoconazole, econazole, miconazole and melaleuca alternifolia (Tea tree oil) against Malessezia species. Antimicrob. Agents Chemother. (2000) 44:467-469.
25. FAERGEMANN J, AUSMA J, BORGERS M: In vitro activity of R126638 and Ketoconazole against Malassezia species. Acta Derm. Venereol. (2006) 86:312-315.
26. DEGREEF H, HEERES J, BORGERS M: Antifungal azoles for skin disorders. Expert Opin. Ther. Patents (2006) 16(9):1235-1253.
27. FAERGEMANN J, BORGERS M: The effect of ketoconazole and itraconazole on the filamentous form of Pityrosporum ovale. Acta Derm. Venereol. (1990) 70:172-176.
28. VAN CUTSEM J, VAN GERVEN F, CAUWENBERGH G et al.: A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus; aureus on the skin of guinea pigs. J. Am. Acad. Dermatol. (1991) 25:257-261.
29. FAERGEMANN J, BERGBRANT IM, DOHSE M, SCOTT A. WESTGATE G: Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis - characterisation of inflammatory cells and mediators in the skin by immunohistochemistry. Br. J. Dermatol. (2001) 144:549-556.
30. DEGREEF H, JACOBS PH, ROSENBERG EW, SHUSTER S: Ketoconazole in seborrhoeic dermatitis and dandruff, a review. ADIS Press Int. Ltd., Manchester (1989).
31. HEEL RC: Chapters V-XXI. In: Ketaconazole in the Management of Fungal Disease. Levine HB (Ed.), ADIS Press, Sydney, Australia (1982)
32. VAN CUTSEM J: The antifungal effect of ketoconazole. Am. J. Med. (1983) 74:9-15.
33. SOHNLE P, COLLINS-LECH C: Activation of complement by Pityrosporum orbiculare. J. Invest. Dermatol. (1983) 129:533-540.
34. KATSAMBAS A, ANTONIOU CH, FRANGOULI E, AVGERINOU G et al.: A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. Br. J. Dermatol. (1989) 121:353-357.
35. BEETENS JR, LOOTS W, SOMERS Y et al.: Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Biochem. Pharmarol. (1986) 35(6):883-891.
36. DE PEDRINI P, RAPISARDA R. SPANO G: The effect of ketoconazole on sebum secretion in patients suffering from acne and seborrhoea. Int. J. Tissue React. (1988) 10(2):111-113.
37. PIÈRARD GE, RIES G, CAUWENBERGH G: New insight into the topical management of excessive sebum flow at the skin surface. Dermatology (1998) 196:126-129.
38. AERTS F, DE BRABANDER M, VAN DEN BOSSCHE H et al.: The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Mykosen (1980) 23:53-67
39. VERFAILLE C, BOLS L, BORGERS M et al.: Analyse comparative de l'activité de 3 generations d'agents inhibiteurs du métabolisme de l'acide rénoique dans des cultures de kératinocytes épidermiques humains normaux. Act. Ingén. Cut. (2006) 4:288-291.
40. BEGER B, HIGHTON A, LEGENDRE R: The irritation potential of topical formulations containing ketoconazole 2% and desonide 0.05% alone and in combination. J. Am. Acad. Dermatol. (2005) 52:61.
41. BEGER B, HIGHTON A, BARRANCO C et al.: A double-blind, randomized, vehicle-controlled, parallel group, multicenter study to assess the efficacy and safety of a topical gel product containing ketoconazole SP 2% in the treatment of Seborrhoeic dermatitis. J. Am. Acad. Dermatol. (2005) 52:122.
42. Investigators Brochure Ketoconazole USP 2% Topical Gel 2004. Barrier Therapeutics, Inc. Available on request.